Abramson Cancer Center, University of Pennsylvania — Philadelphia, Pennsylvania

Abramson Cancer Center, University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center, University of Pennsylvania has participated in 10 clinical trials with 3 currently active.

Therapeutic areas: Renal Cell Carcinoma 4, Large B Cell Lymphoma, Non Hodgkin Lymphoma (NHL).

Sponsors: Abramson Cancer Center at Penn Medicine, University of Pennsylvania, Laura Huppert, MD, BA.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center, University of Pennsylvania?

Abramson Cancer Center, University of Pennsylvania has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center, University of Pennsylvania conducted?

Abramson Cancer Center, University of Pennsylvania has 10 clinical trials on record, with 3 currently active. Their work covers Renal Cell Carcinoma 4, Large B Cell Lymphoma, Non Hodgkin Lymphoma (NHL).

Is Abramson Cancer Center, University of Pennsylvania accredited by Crixeo Health?

Yes — Abramson Cancer Center, University of Pennsylvania holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Abramson Cancer Center, University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.